Related Experiment Video
Updated: Jun 5, 2025

15:31
MISSION esiRNA for RNAi Screening in Mammalian Cells
Published on: May 12, 2010
16.3K
Structural basis for gene silencing by siRNAs in humans
Sucharita Sarkar1,2, Luca F R Gebert1,2, Ian J MacRae1
1Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Biorxiv : the Preprint Server for Biology
|December 16, 2024
Summary
Structural insights into human Argonaute2 (hAgo2) reveal how small interfering RNAs (siRNAs) catalyze target mRNA cleavage. Disrupting siRNA 3'-end binding stabilizes hAgo2, enabling detailed structural analysis of gene silencing.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Small interfering RNAs (siRNAs) are crucial for targeted gene silencing via mRNA cleavage mediated by human Argonaute2 (hAgo2).
- Despite their significance in research and therapeutics, the precise structural mechanisms underlying hAgo2's catalytic activity remain poorly understood.
Purpose of the Study:
- To elucidate the structural basis of siRNA-mediated mRNA cleavage by human Argonaute2 (hAgo2).
- To provide high-resolution structural insights into the catalytic mechanism of hAgo2 for therapeutic design.
Main Methods:
- Cryo-electron microscopy (cryo-EM) was employed to determine the structure of hAgo2 with a modified siRNA-target duplex.
- Biochemical assays were used to assess the impact of structural modifications on catalytic activity.
Main Results:
- Disrupting siRNA 3'-end binding to hAgo2 stabilized the enzyme's catalytic conformation, facilitating structural analysis.
- A 3.16 Å cryo-EM reconstruction revealed key interactions, including target RNA entry into the catalytic cleft and the roles of previously unrecognized catalytic residues Lysine-709 and Arginine-710.
- Specific nucleotide positioning and duplex major groove dynamics were shown to be critical for docking the scissile phosphate and facilitating target RNA hydrolysis and release.
Conclusions:
- The study reveals the detailed mechanism of siRNA target hydrolysis by hAgo2, highlighting specific residue interactions and conformational changes.
- A high-resolution structural model of hAgo2's catalytic activity is presented, offering valuable insights for the rational design of RNA interference-based therapeutics.
Related Concept Videos
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
Small interfering RNAs (siRNA)
3.5K
3.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
piRNA - Piwi-interacting RNAs
6.8K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.8K

